Tandem Diabetes Care Inc [TNDM] stock prices are up 5.39% to $23.26 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The TNDM shares have gain 5.20% over the last week, with a monthly amount glided 19.28%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Tandem Diabetes Care Inc [NASDAQ: TNDM] stock has seen the most recent analyst activity on December 16, 2025, when Robert W. Baird upgraded its rating to a Outperform but kept the price target unchanged to $30 for it. On September 08, 2025, Oppenheimer initiated with a Outperform rating and assigned a price target of $22 on the stock. Citigroup upgraded its rating to a Neutral but stick to its price target of $10.35 on August 12, 2025. Piper Sandler downgraded its rating to a Neutral but $14 remained the price target by the analyst firm on August 07, 2025. Citigroup downgraded its rating to Sell for this stock on July 09, 2025, but kept the price target unchanged to $14. In a note dated June 16, 2025, Truist initiated an Hold rating and provided a target price of $24 on this stock.
The stock price of Tandem Diabetes Care Inc [TNDM] has been fluctuating between $9.98 and $38.28 over the past year. Currently, Wall Street analysts expect the stock to reach $24.88 within the next 12 months. Tandem Diabetes Care Inc [NASDAQ: TNDM] shares were valued at $23.26 at the most recent close of the market. An investor can expect a potential return of 6.96% based on the average TNDM price forecast.
Analyzing the TNDM fundamentals
The Tandem Diabetes Care Inc [NASDAQ:TNDM] reported sales of 1.01B for trailing twelve months, representing a surge of 2.17%. Gross Profit Margin for this corporation currently stands at 0.53% with Operating Profit Margin at -0.19%, Pretax Profit Margin comes in at -0.2%, and Net Profit Margin reading is -0.2%. To continue investigating profitability, this company’s Return on Assets is posted at -0.23, Equity is -1.19 and Total Capital is -0.32. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 3.38.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.19 points at the first support level, and at 21.11 for the second support level. However, for the 1st resistance point, the stock is sitting at 24.20, and for the 2nd resistance point, it is at 25.13.
Ratios To Look Out For
It’s worth pointing out that Tandem Diabetes Care Inc [NASDAQ:TNDM]’s Current Ratio is 2.44. Also, the Quick Ratio is 1.90, while the Cash Ratio stands at 0.36. Considering the valuation of this stock, the price to sales ratio is 1.57, the price to book ratio is 11.86.
Transactions by insiders
Recent insider trading involved Sheridan John F, PRESIDENT & CEO, that happened on Aug 11 ’25 when 10000.0 shares were purchased. EVP & CHIEF FINANCIAL OFFICER, Vosseller Leigh completed a deal on Aug 08 ’25 to buy 13720.0 shares. Meanwhile, EVP & Chief Operating Officer Kyrillos Jean-Claude bought 10538.0 shares on Mar 07 ’25.
